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Correlation ofSkin Tests, Serological Testsfor IgEAntibody, Provocation Tests and the Clinical History There are many reports of poor correlations between intracutaneous tests, provocation tests and the history (Aas 1969) . The presence of allergen specific IgE by contrast correlates well With provocation tests.
An investigation of the prick test with extracts of Dermatophagoides pteronyssinus, D. farina, and grass pollen in asthmatic subjects with house dust and grass pollen allergy, by Stenius et al. (1971) , has shown a very good correlation between the reactions and the presence of allergen-specific IgE, provocation tests and the history. Prick tests gave positive reactions with all three extracts in almost all the subjects with positive serological tests for the relevant specific IgE antibody. The sizes of the weals showed highly significant statistical correlations with the amounts of the specific IgE antibodies. Immediate nasal test reactions were obtained with D. farina in 19 subjects of whom all but 2 had positive IgE tests and 17 had a positive history of house dust allergy. In 19 giving negative nasal tests, 3 had very low IgE positive and 2 had a positive history. Intracutaneous tests in the subjects giving negative prick tests to D. farine gave positive reactions in 7 out of 14; though 2 out of 9 tested gave positive nasal reactions neither of these had positive IgE reactions. Similar findings were obtained with grass pollen extract tests. The prick test, therefore, with appropriate extracts, serves to identify almost all the subjects with specific IgE antibody and correlates as well with provocation tests and the clinical history as the serological test for specific IgE. Type I Reactions in Atopic and Non-atopic Subjects with Avian Allergy In 5 atopic patients with asthma due to avian allergens, who gave immediate asthmatic reactions to inhalation tests, prick tests gave strong reactions to the avian and other common allergens. All had specific IgE antibody to the avian allergens.
Of 17 non-atopic subjects with mainly allergic alveolitis, and 1 patient with a 'late' asthmatic reaction, 7 gave weaker reactions to prick tests with avian allergens and 2 gave reactions to other common allergens. Only 2 of the 17 gave weakly positive specific IgE tests to avian allergens. Thus, the atopic subjects with avian specific IgE antibody gave immediate asthmatic reactions as would be expected from IgE mediated reactions, whereas in the non-atopic subjects no immediate asthmatic reactions were elicited. On intracutaneous testing with the avian allergens, most of the non-atopic subjects gave positive immediate reactions. In view of the absence of avian-specific IgE antibody, other antibodies must be regarded as responsible. Investigations are being made into the possibility that the IgG antibody reported by Parish (1970) may be responsible. In these non-atopic subjects precipitating antibodies were present in the IgG, IgM and IgA classes, and their late asthma or alveolitis reactions have been attributed to immune-complex reactions.
Conclusions
The interpretation of Type I skin test reactions can be guided up to a point by whether the subject has evidence of 'atopic' sensitivity in the form of immediate reactions to common allergens, both on skin and inhalation tests and on clinical exposure. Prick testing minimizes the numbers of 'false positive' reactions in terms of IgE antibody. Similar correlations of prick test reactions and the presence of specific IgE antibody against other common allergens are required.
The possibility that immediate reactions to prick tests, or positive reactions to intracutaneous tests in subjects giving negative reactions to the prick test, may be mediated by antibodies other than IgE also needs further study and clinical assessment. This may occur in subjects usually regarded as non-atopic, who do not react to other common allergens and do not give immediate reactions on challenge or clinical exposure. The association of both together, or perhaps of other immunological mechanisms mediating immediate reactions, cannot be excluded. The problem of respiratory allergy due to the complex salts of platinum, its symptomatology, sequele, incidence and the hazards of investigation have been well described (Hunter et al. 1945 , Bijl 1963 , Hebert 1966 , Roberts 1951 .
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Our object was to develop a method of exposure to the complex salts ofplatinum which was safe and reproducible and which produced the minimum of discomfort in the patient. These investigations were carried out on twelve patients who had developed symptoms of asthma and rhinitis, suggestive of platinum sensitivity, while working in a platinum refinery.
Methods and Materials
(1) Skin prick tests: Solutions of three complex platinum salts, ammonium hexachlorplatinate, ammonium tetrachlorplatinate and sodium hexachlorplatinate, were prepared. The complex salts were dissolved in carbol saline in tenfold dilutions at concentrations from 10 3 to 10 g/ml.
Fifteen normal subjects had negative skin tests at the highest concentrations of all three complex salts.
(2) Nasal tests: Solutions of the same three complex platinum salts in serial dilutions ranging from 10-3 to 10-11 g/ml were used. The test consisted of the introduction into one nostril of 0 05 ml of solution, initially a control solution of carbol saline, and subsequently solutions of complex platinum salts commencing at the lowest dilution. A nasal reaction was considered positive if itching, sneezing, nasal obstruction' or discharge occurred singly or in combination, within 15 minutes of the challenge.
Fifteen normal subjects had negative nasal tests at the highest concentrations of all three complex salts.
(3) 'Inhalation' tests: Inhalation test materials were made up by suspending 40 mg of each complex platinum salt in 1,000 g lactose; because of the hygroscopic nature of lactose this suspension was then dried for 20 hours at 105°C and subsequently stored in a dessicator. A control 'inhalation' test using plain lactose (identical in appearance to the platinum/lactose mixtures) was performed in all patients to assess nonspecific reactions and to check diurnal variations in forced expiratory volume (FEVy) and forced vital capacity. The test itself was performed in a small cubicle of 240 cu. ft (6-8 m3). The patient shook 250 g of the p'owder from one tray into another placed 1 ft '(0 3 m) below it. This manceuvre was carried out repetitively for a maximum of 30 minutes. Three different types of bronchial reaction were seen: (a) An immediate asthmatic reaction only, maximal at '10 minutes after cessation of the challenge and resolving in one hour. (b) A late reaction (L1) without any preceding immediate reaction, which appeared only with ammonium tetrachlorplatinate, commencing at 60 minutes, maximal at 2-3 hour's'and resolving in 4-5 hours.
(c) An immediate and late asthmatic reaction, the late component (L2) commencing at 3-4 hours, maximal at 6-8 hours and resolving in 24 hours.
Results
Twelve patients were investigated. Initially, investigation was by inhalation testing with ammonium hexachlorplatinate only; later skin, nasal and inhalation tests with the three complex platinum salts were introduced. Six patients have now been investigated by skin, nasal and inhalation tests with the three complex salts. One patient has had skin, nasal and bronchial inhalation tests with ammonium hexachlorplatinate and an inhalation test with sodium hexachlorplatinate. The remaining 5 patients have had inhalation tests with ammonium hexachlorplatinate only.
Skin tests were made in 7 patients. Of these, 6 were positive to all three complex platinum salts at concentrations of either 10 -or 10 g/ml. One patient was negative at 10 -3 g/ml to the three complex platinum salts.
Nasal challenge tests were made in the same 7 patients. One patient was negative with all three complex salts; 6 patients were positive to ammonium and sodium hexachlorplatinate and 5 of these reacted to ammonium tetrachlorplatinate. All positive challenge tests occurred at concentrations from 10to 10-5 g/ml. (L2) and 6 had no asthmatic reactions. (b) Ammonium tetrachlorplatinate: Six patients were investigated; 4 had immediate asthmatic reactions only and 2 had isolated late asthmatic reactions (L1) differing from the above. (c) Sodium hexachlorplatinate: Seven patients were investigated; 3 had immediate asthmatic reactions; the remaining 4 had no asthmatic reactions. Table 1 summarizes the findings.
Discussion
Six patients were investigated by skin, nasal and inhalation tests to ammonium hexachlorplatinate, ammonium tetrachlorplatinate and sodium hexachlorplatinate. There was a good correlation between positive skin, nasal and bronchial tests with ammonium hexachlorplatinate and ammonium tetrachlorplatinate and of skin and nasal tests with sodium hexachlorplatinate.
The results following this method of exposure were reproducible. For example, in one individual, characteristic of the group, comparable challenges on three consecutive days produced falls in FEV1 of 38%, 42% and 32%.
The investigation of these patients in the past has been complicated by anaphylactic reactions (Levene & Calnan 1971 , Vallery-Radot & Blamoutier 1929 , Freedman & Krupey 1968 , following scratch or intracutaneous tests with solutions of the same complex platinum salts. By using prick tests with low concentrations of these solutions, we totally avoided systemic reactions in our patients. Similarly, none of the asthmatic reactions precipitated by this method of 'inhalation' testing required reversal by sympathomimetics or other agents. and Occupational Medicine 4, 549
The following paper was also read: Cryoglobulins, i.e. globulins that precipitate in the cold and redissolve on warming, were first noted in the serum of a patient with myeloma by Wintrobe & Buell in 1933. Subsequent studies using analytical ultracentrifugation and specific antisera showed that cryoglobulins were of two typesa homogeneous or single component type and a heterogeneous or mixed component variety (Table 1) . Mixed cryoglobulins can be regarded as immune complexes, the evidence for this being that: (1) the separated components of the cryoglobulin will not precipitate in the cold but on remixing cryoprecipitation once again occurs;
(2) one immunoglobulin can be shown to be an antiglobulin antibody directed against the IgG component ( Arthus-like reactions may develop after intradermal injections in man (Whitsed & Penny 1971) .
The presence of cryoglobulins in serum may be overlooked because they occasionally fail to sediment and remain suspended as a fine cloud, or they precipitate only after the serum has been
